3 Factor Indexing’s Bio-Techne TECH Stock Holding History

3 Factor Indexing’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$142	Sell	2 -1	-33%	-$54	﹤0.01%	349
2026 Q1	$157	Buy	+3	New	+$180	﹤0.01%	331

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

3 Factor Indexing's TECH Position: Q2 2026 in Review

3 Factor Indexing reduced its Bio-Techne (TECH) stake by 33% in Q2 2026, selling an estimated $54 and leaving 2 shares worth $142. The position accounts for ﹤0.01% of the portfolio, ranked #349.

3 Factor Indexing first reported a position in TECH in Q1 2026 and has held it in 2 quarters since. The position peaked at $157 in Q1 2026. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

3 Factor Indexing held 2 shares of Bio-Techne worth $142 as of Q2 2026.
3 Factor Indexing sold 1 Bio-Techne share in Q2 2026, an estimated $54.
Bio-Techne made up ﹤0.01% of 3 Factor Indexing's portfolio in Q2 2026, its #349 holding.
3 Factor Indexing first reported a position in Bio-Techne in Q1 2026 and has held it in 2 quarters since.
3 Factor Indexing's Bio-Techne position peaked at $157 in Q1 2026.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on 3 Factor Indexing's 13F filing for Q2 2026, filed 8 Jul 2026.